From the Editor-in-Chief

Researchers search for reasons for the growing number of cases in people under 50.

by William G. Nelson, MD, PhD

The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

by Sandra Gordon

Studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.

by Cancer Research Catalyst

SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.

by Marci A. Landsmann

From the Editor-in-Chief

Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.

by William G. Nelson, MD, PhD

Forward Look

Surgical oncologist Samilia Obeng-Gyasi describes research that shows chronic stress is associated with higher mortality in cancer.

by Ashley P. Taylor

Forward Look

A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.

by Darcy Lewis

Forward Look

Study supports the use of immune checkpoint inhibitors in an understudied population.

by Carolyn Bernhardt

Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.

by Cameron Walker

Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.

by Erin O’Donnell